Product ID |
Product Name |
CAS# |
Purity |
Y3175751 |
ALPK1-IN-3 |
2765633-73-4 |
98% |
Y3297622 |
ANAT inhibitor-2 |
1048244-34-3 |
99% |
Y3294344 |
CYP11A1-IN-1 |
2744168-51-0 |
99% |
Y3287080 |
(Z)-ONO 1301 |
153814-74-5 |
95% |
Y3289461 |
CL-197 |
1030595-07-3 |
99% |
Y3171969 |
Phytoene desaturase-IN-1 |
2765793-54-0 |
99% |
Y3287834 |
LW3 |
2803367-68-0 |
99% |
Y3296628 |
iBRD4-BD1 |
2839318-17-9 |
98% |
Y3288114 |
BET-IN-14 |
2243669-93-2 |
99% |
Y3307595 |
PBRM1-BD2-IN-2 |
2819989-57-4 |
100% |
Y3290207 |
SARS-CoV-2-IN-39 |
2882823-03-0 |
99% |
Y3295892 |
Cbl-b-IN-5 |
2368835-59-8 |
99% |
Y3175755 |
PBRM1-BD2-IN-5 |
2819989-61-0 |
99% |
Y3181339 |
VT02956 |
2999763-09-4 |
99% |
Y3307639 |
PROTAC IRAK4 degrader-3 |
2374122-43-5 |
97% |
Y3317197 |
m-PEG37-acid |
2924199-92-6 |
95% |
Y3311503 |
PSMa3 |
1001405-52-2 |
98% |
Y3310198 |
CLEFMA |
1246964-32-8 |
98% |
Y3177183 |
3-amino-N-methylbicyclo[1.1.1]pentane-1-carboxamide hydrochloride |
2742653-23-0 |
95% |
Y3286664 |
methyl (2R)-2-{[(tert-butoxy)carbonyl]amino}-3-hydroxy-3-methylbutanoate |
2639390-57-9 |
95% |
Y3118969 |
tert-Butyl 4-bromo-5-chloro-1H-indole-1-carboxylate |
1191028-42-8 |
97% |
Y3305548 |
4-{[(tert-butoxy)carbonyl]amino}-3-cyclopropylbutanoic acid |
2161930-85-2 |
95% |
Y3287869 |
2-[(tert-butoxy)carbonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid |
1824264-71-2 |
95% |
Y3292906 |
(2E)-3-(3-{[(tert-butoxy)carbonyl]amino}phenyl)prop-2-enoic acid |
1041867-60-0 |
95% |
Y3296825 |
tert-butyl N-(6-bromopyrimidin-4-yl)carbamate |
2091424-72-3 |
95% |
Y3309307 |
(1S,4S)-2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-2-azabicyclo[2.2.1]heptane-4-carboxylic acid |
2803758-41-8 |
95% |
Y3315396 |
tert-butyl N-[2-hydroxy-1-(pyridin-2-yl)ethyl]carbamate |
213990-60-4 |
97% |
Y3295683 |
methyl 2-amino-1-ethyl-1H-1,3-benzodiazole-5-carboxylate |
1781181-41-6 |
95% |
Y3285700 |
2-{1-[(tert-butoxy)carbonyl]piperidin-2-yl}-2-phenylacetic acid |
1800423-96-4 |
95% |
Y3317947 |
potassium (3-bromo-2-fluorophenyl)trifluoroboranuide |
1870888-57-5 |
95% |
Y3292080 |
(2,3,5-trimethoxyphenyl)boronic acid |
483989-31-7 |
95% |
Y3309024 |
3-amino-1-imino-1lambda6-thiolan-1-one |
2680793-24-0 |
95% |
Y3285816 |
rac-tert-butyl N-[(1R,3S)-3-ethynylcyclohexyl]carbamate |
1474041-11-6 |
95% |
Y3178952 |
3-[5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]naphthalen-2-ol |
2094620-45-6 |
95% |
Y3287513 |
1-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-pyrazole-4-carboxylic acid |
2138266-33-6 |
95% |
Y3177022 |
7-bromo-4-methyl-1H-indole-3-carbonitrile |
1360937-13-8 |
95% |
Y3175381 |
1-ethynyl-4-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexane |
2503208-69-1 |
95% |
Y3291875 |
methyl 6-bromo-2-chloro-5,7-difluoroquinoline-3-carboxylate |
2137535-76-1 |
95% |
Y3309335 |
2-(4-ethylcyclohexyl)acetaldehyde |
1165941-61-6 |
95% |
Y3295132 |
2-amino-N-(5-nitro-thiazol-2-yl)-benzamide |
34952-17-5 |
95% |
Y3289737 |
2-(2-Methoxy-benzamino)-5-nitro-thiazol |
69818-97-9 |
95% |
Y3296615 |
2-chloro-N-(5-nitro-1,3-thiazol-2-yl)benzamide |
69819-38-1 |
97% |
Y3293118 |
2-methyl-N-(5-nitro-1,3-thiazol-2-yl)benzamide |
69818-95-7 |
97% |
Y3310857 |
Eubulus-A80 |
2703776-20-7 |
95% |
Y3305811 |
4-Methyl-6-(1-methylethyl)-3-(phenylmethyl)-2,5-morpholinedione |
2180287-51-6 |
95% |
Y3307569 |
1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl] |
2171015-78-2 |
99% |
Y3292754 |
UCM-1336 |
1621535-90-7 |
99% |
Y3304721 |
JAB-2485 |
2899209-55-1 |
98% |
Y3307040 |
Biguanidinium-porphyrin |
1014978-87-0 |
93% |
Y3317984 |
4-(chloromethyl)-1,1-difluorocyclohexane |
1545679-12-6 |
95% |
Y3310964 |
6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile |
1314134-92-3 |
97% |
Y3310774 |
(+)-Picumeterol |
139423-79-3 |
98% |
Y3308856 |
Methyl (E)-sinapate |
42041-51-0 |
98% |
Y3306621 |
Ly-295501 |
150869-74-2 |
98% |
Y3310347 |
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxole, pregn-4-ene-3,20-dione deriv |
144459-71-2 |
97% |
Y3309281 |
TGFß1-IN-3 |
2883813-58-7 |
99% |
Y3311674 |
(Iso)-Atagabalin HCl |
223445-68-9 |
99% |
Y3310699 |
isomer-GAT 107 |
1426240-47-2 |
100% |
Y3311569 |
(2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide |
1354546-42-1 |
99% |
Y3290279 |
SRD5A1-IN-1 |
2279077-93-7 |
99% |
Y3309377 |
(Iso)-RJW100 |
1276664-61-9 |
99% |
Y3304560 |
DB722 |
433735-90-1 |
99% |
Y3311359 |
isomer-Cilansetron |
120635-77-0 |
99% |
Y3309859 |
2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]- |
1021917-65-6 |
99% |
Y3307402 |
MMP-9-IN-6 |
2241964-36-1 |
99% |
Y3297014 |
JNJ-1289 |
792898-18-1 |
98% |
Y3308692 |
AP-C2 |
682793-07-3 |
100% |
Y3305581 |
isomer-CM 352 |
1542205-84-4 |
97% |
Y3310616 |
Elziverine |
95520-81-3 |
98% |
Y3310195 |
mTOR inhibitor 13 |
1144075-44-4 |
99% |
Y3307557 |
CIA-1 (Free base) |
452087-38-6 |
95% |
Y3310398 |
mTOR inhibitor 9e |
1144075-40-0 |
98% |
Y3310014 |
1H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester |
539807-13-1 |
99% |
Y3306230 |
UB 165 fumarate |
2454492-43-2 |
100% |
Y3308750 |
YM-58790 |
168830-70-4 |
98% |
Y3306192 |
Ibezapolstat hydrochloride |
1275582-98-3 |
99% |
Y3304572 |
BAY-43-9695 |
233255-39-5 |
99% |
Y3311646 |
Tetrazolast |
95104-27-1 |
95% |
Y3308342 |
NK01-63 |
2922281-15-8 |
95% |
Y3240852 |
TAM558 intermediate-5 |
1415659-15-2 |
95% |
Y3181138 |
Rac1-IN-3 |
380470-06-4 |
98% |
Y3175852 |
Vaxfectin |
370108-99-9 |
98.12% |
Y3175853 |
LNP Lipid-7 |
1190203-55-4 |
95% |
Y3177413 |
ARD-1676 |
2632305-36-1 |
98.05% |
Y3297585 |
YK-029A |
2064269-82-3 |
99% |
Y3289997 |
AN-12-H5 |
1193340-31-6 |
98% |
Y3175480 |
Gepirone-d8 |
2749331-28-8 |
98.0% |
Y3288703 |
Pimicotinib |
2253123-16-7 |
99% |
Y3295823 |
Halo-DBCO |
1808119-16-5 |
98% |
Y3290775 |
MNK1/2-IN-5 |
1426928-20-2 |
99% |
Y3293007 |
AZT triphosphate tetraammonium |
106060-92-8 |
99% |
Y3306861 |
LCB 03-0110 dihydrochloride |
1962928-28-4 |
99% |
Y3297980 |
4'-Propyl[1,1'-biphenyl]-4-acetic acid |
1000516-52-8 |
95% |
Y3311915 |
Hexa-His TFA |
1456728-20-3 |
99% |
Y3185492 |
5'-Des-O-methylharringtonine |
182325-73-1 |
99.80% |
Y3173729 |
ß-catenin-IN-3 |
1005288-15-2 |
98.03% |
Y3290724 |
Taltobulin intermediate-2 |
91133-59-4 |
97% |
Y3178669 |
BODIPY 540 (purity 99%) |
1446240-77-2 |
95% |
Y3180506 |
5'-Methylthioadenosine-13C6 |
2421187-73-5 |
95% |
Y3171272 |
Cyanine3 DBCO hexafluorophosphate |
2692677-79-3 |
95.01% |